Dermorphin

🧬 Core Mechanisms:

• Ultra-Selective $\mu$-Opioid Receptor Hyper-Agonism: Functions as a naturally derived synthetic heptapeptide that exhibits extraordinary binding affinity and structural selectivity for the $\mu$-opioid receptor ($MOR$) family, far surpassing morphine and endogenous enkephalins in potency.

• D-Amino Acid Conformational Stability: Incorporates a unique D-alanine residue at position 2 of its amino acid sequence. This rare stereochemical configuration renders the peptide highly resistant to standard enzymatic degradation, ensuring prolonged central and peripheral receptor occupancy.

🌟 Why Choose Dermorphin?

• Extreme Analgesic Potency: Extensively documented in neurological and pain research to produce profound, long-lasting antinociception (pain suppression) at micro-dose concentrations, serving as a premier compound for studying spinal and supraspinal pain pathways.

• Advanced Neuroendocrine Signaling Modulation: Modulates downstream neuroendocrine axes, significantly altering the release profiles of pituitary hormones such as prolactin, growth hormone, and ACTH through targeted central nervous system pathways.

• Precision Gastrointestinal Kinetic Modeling: Demonstrates highly efficient, selective inhibitory control over gastrointestinal motility and transit times, making it an essential baseline standard in smooth muscle kinetic and opioid-induced bowel dysfunction research.

• Behavioral & Reward Pathway Architecture: Acts as a powerful molecular probe for investigating the complex mechanics of opioid-induced reward systems, respiratory depression thresholds, and receptor trafficking/desensitization behaviors.

Note: All products are intended for laboratory and scientific research purposes only. Not FDA-approved. Not for human or animal consumption